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Sterol regulatory element-binding proteins (SREBPs)
are key transcriptional regulators of lipid metabo-
lism. To define functional differences between the
three mammalian SREBPs we used genome-wide
ChIP-seq with isoform-specific antibodies and chro-
matin from select tissues of mice challenged with
different dietary conditions that enrich for specific
SREBPs. We show that hepatic SREBP-2 binds pref-
erentially to two different gene-proximal motifs. A
Gene Ontology (GO) analysis suggests SREBP-2
targets lipid metabolic processes as expected, but
apoptosis and autophagy gene categories were
also enriched. We show that SREBP-2 directly acti-
vates autophagy genes during cell-sterol depletion,
conditions known to induce both autophagy and
nuclear SREBP-2 levels. Additionally, SREBP-2
knockdown during nutrient depletion decreased
autophagosome formation and lipid droplet associa-
tion of the autophagosome targeting protein LC3.
Thus, the lipid droplet could be viewed as a third
source of cellular cholesterol, which along with sterol
synthesis and uptake, is also regulated by SREBP-2.
INTRODUCTION
The structural framework of all biological membranes is based
on the unique molecular properties of lipids (van Meer et al.,
2008). Lipids also have more specialized roles that have evolved
over time that influence many physiologic pathways and
processes that vary based on organism, tissue, developmental
timing, cellular physiology, and metabolic demand (Di Paolo
and De Camilli, 2006; Mann and Beachy, 2004; Toker and Cant-
ley, 1997). Accordingly, the need for new lipid in a given cell can
vary dramatically and change quickly, so it is essential that
a dynamic and flexible regulatory mechanism is evolving at the
cellular level that is based on both need and availability.
An integrated regulatory system for mammalian lipid homeo-
stasis operates at both transcriptional and posttranscriptionalClevels (Brown and Goldstein, 1980). Amajor part of the transcrip-
tional control is through the sterol regulatory element-binding
proteins (SREBPs), which comprise a subfamily of basic helix-
helix (bHLH) proteins and are conserved from simple eukaryotes
to humans (Osborne and Espenshade, 2009). SREBPs are
synthesized and threaded into the endoplasmic reticulum
membrane, where two closely spaced membrane-spanning
domains position the precursor molecule in a hairpin configura-
tion. When the cellular supply of lipids is limiting, SREBPs are
routed to the Golgi apparatus and cleaved roughly in half by
the action of two sequential-acting membrane-bound proteases
that release the soluble amino-terminal mature SREBP transcrip-
tion factor from the membrane. Mature SREBP is constitutively
targeted to the nucleus, where it activates genes required for
synthesizing fatty acids and cholesterol (Osborne and Espen-
shade, 2009).
Two separate SREBP genes, Srebf1 and Srebf2, encoding
three major protein isoforms, have evolved in mammals, and
a combination of genetics and molecular expression studies
in mice and cultured cells has been used to study isoform-
specific roles in lipid metabolism (Horton et al., 2002). The
two proteins expressed from the Srebf1 gene, SREBP-1a
and SREBP-1c, have the identical DNA-binding domain, and
available evidence suggests they both preferentially target
genes of fatty acid metabolism, whereas the singular Srebf2-
encoded protein preferentially activates genes of cholesterol
metabolism (Horton et al., 2002). However, studies indicate
there is considerable overlap in function, and a few reports
also suggest SREBPs may be involved in activating other
physiological processes, so further investigation is required
to fully appreciate the broad roles of the three mammalian
SREBP isoforms at the molecular level (Osborne and Espen-
shade, 2009).
We are complementing the overexpression and knockout
investigations with genome-wide DNA binding studies to further
interrogate SREBP function using a global and unbiased
approach. In the current report, we have used an antibody to
SREBP-2 in a chromatin immunoprecipitation (ChIP)-deep
sequencing approach (ChIP-seq) (Johnson et al., 2007) that re-
vealed 1800 sites of SREBP-2 binding in mouse liver chromatin.
In addition to identifying genes in pathways of lipid metabolism,
this analysis also identified several genes involved in autophagy
as potential SREBP targets.ell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc. 367
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Figure 1. Validation for SREBP-2 Antibody
and Chromatin Supplemented by Chow
and Chow with LE
(A and B) Immunofluorescence of SREBP-2 in
mouse liver from normal chow (A) or chow sup-
plemented with lovastatin and ezetimibe (LE) for
1 week (B). Liver pieces were embedded in para-
formaldehyde, sectioned, and stained with a rabbit
anti-SREBP-2 polyclonal antibody (affinity puri-
fied), followed by fluorescein-labeled goat anti-
rabbit IgG. Magnification, 400 3 bar shows scale
for 10 mm.
(C) Hepatic nuclear extracts were prepared from
mice fed chow and LE diets.
(D) Gene-specific ChIP analysis using chromatin
from the LE group that was immunoenriched with
an antibody to SREBP-2 (black bars) or a control
IgG (white bars). Gene-specific primers for the
indicated promoter regions were used in the
qPCR. Data are mean ± SEM; n = 3 for three
separate experiments.
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SREBP-2 Regulates AutophagyAutophagy provides a catabolic quality control and recycling
mechanism for cells to remove damaged proteins and organelles
and to recapture cellular components when nutrient building
blocks are limiting (He and Klionsky, 2009). Lipid depletion has
already been shown to induce autophagy (Cheng et al., 2006),
and recent studies have suggested that in response to nutrient
limitation cells may recycle excess cellular lipid stored in cyto-
plasmic droplets as cholesterol esters and triglycerides (TGs),
through a process termed macrolipophagy, which requires
many if not all of the same proteins required for autophagy (Singh
et al., 2009). We present additional studies showing that SREBP-
2 activates autophagy genes during sterol depletion and that
autophagosome formation and the association of the key auto-
phagosomal LC3 protein with lipid droplets (LDs) in response to
nutrient depletion are both significantly reduced when SREBP-
2 levels are decreased. Thus, the LD could be considered a third
source of cellular lipid that is also regulated by SREBPs.
RESULTS
In order to evaluate SREBP-2 binding on a genome-wide scale,
we first prepared an antibody to a region of the mouse SREBP-2
within its amino-terminal nuclear-targeted domain that bears no
similarity to the corresponding region of SREBP-1 (Jeon et al.,
2008). Before embarking on the ChIP-seq analysis, we first eval-
uated the specificity and quality of the antibody (Figure 1).
Nuclear levels of hepatic SREBP-2 are significantly elevated in
mice fed a chow diet supplemented with lovastatin plus ezeti-
mibe (LE) to inhibit cholesterol production in the liver and simul-
taneously limit cholesterol uptake from the diet (Bennett et al.,368 Cell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc.2008; Jeon et al., 2008). Sections cut
from control and LE-treated liver were
stained with the SREBP-2 antibody, and
Figure 1A shows strong nuclear reaction
with the LE sample relative to chow-fed
control, which shows diffuse nonnuclear
staining.SREBP nuclear localization results from proteolytic maturation
that cleaves the 120 kDa membrane-bound precursor roughly
in half. An immunoblot analysis confirmed that mature SREBP-2
was increased dramatically in the LE sample (Figure 1C). Next,
chromatin from the LE sample was used in gene-specific chro-
matin immunoprecipitation studies with primers that flank known
SREBP-2 binding sites within key target genes Hmgcr, Ldlr, and
Fasn. These gene-specific ChIP reactions showed significant
enrichment by the SREBP-2 antibody, whereas a genomic frag-
ment from the negative control Yy1 gene was not enriched (Fig-
ure 1D). Based on these results, wewere encouraged to proceed
with the genome-wide binding analysis.
A portion of the DNA used in the confirmation ChIPs in Figure 1
was used in the ChIP-seq procedure for parallel sequencing on
the Solexa/Illumina Genome Analyzer II (San Diego, CA). The
reads returned from the sequencer were then mapped onto the
mouse genome, and putative SREBP-2 binding peaks were
identified using the global identifier of target regions (GLITR)
program (Tuteja et al., 2009). GLITR calculated a false discovery
rate (FDR) for each peak, and we identified all binding peaks that
have an FDR less than 1.5% and a fold change in peak intensity
greater than 10 (relative to the control IgG). The total number of
identified peaks and the number contained within 20 kb of
a known gene are shown in Figure 2A. The sequencing reads
were also overlayed as a track in the UCSC Genome Browser,
and the areas close to peaks associatedwith four different genes
are displayed in Figure S1 as an example of the data set.
The genome-wide distribution of the peaks relative to the posi-
tion of known genes is shown in Figure 2B. It is striking to note
that 77% of the binding sites are localized to a region located
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Figure 2. ChIP-Seq Analysis for SREBP-2 Distribution on Mouse
Liver Chromatin Supplemented with LE
(A) Summary of ChIP-seq analysis by GLITR. The results were obtained using
an FDR of 1.5% and a fold change in peak intensity of 10 relative to control IgG
as cut-off values.
(B) Genome-wide mapping of SREBP-2 binding regions relative to RefSeq
mouse genes. The ‘‘promoter’’ and ‘‘downstream’’ are defined as 2 kb of 50 or
30 flanking sequence. ‘‘Intergenic region’’ refers to all locations other than
promoter, 50 UTR, exon, intron, 30 UTR, or downstream. FDR, false discovery
rate; FC, fold change. The total number of SREBP-2 peaks was 1800 (100%).
These were distributed in the genome as follows: promoter, 1398 (77.6%);
exon, 44 (2.4%); downstream, 18 (1.0%); 30 UTR, 11 (0.61%); 50 UTR, 146
(8.1%); intergenic, 124 (6.9%); intron, 59 (3.3%).
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SREBP-2 Regulates Autophagywithin 2 kb of the 50 end of known genes. By contrast, if the peaks
were randomly sampled from the genome, only 38 siteswould be
expected to be present in this region (Figure S2A), demon-
strating a strong enrichment of SREBP-2 sites in proximal
promoter regions (p value < 106). Note that this preference of
binding for proximal promoter regions is highly unusual, since
most transcription factor binding sites studied by ChIP-seq
tend to show more widely distributed binding throughout the
entire genome (Seo et al., 2009). The gene-proximal location of
the binding sites was also revealed by a plot of the distance of
each peak relative to a transcription start site (TSS) for a known
gene (Figure S2B).
Because of the very high number of short sequence reads,
Johnson et al. (2007) suggested that the ChIP-seq procedure
would identify binding sites very accurately. When we evaluated
the sequence reads at the Hmgcr promoter relative to our previ-
ously published DNase I footprinting analysis using recombinant
SREBP and 32P-labeled DNA from this region in vitro (Vallett
et al., 1996), the enrichment of the ChIP-seq reads correlated
very precisely with the three regions of DNA protected by re-
combinant SREBP in vitro (Figure S3). This provides a compelling
example of the congruence of the in vitro and in vivo DNA binding
studies.CTo evaluate how the genome-wide binding analysis correlates
with global regulation of gene expression by SREBP-2, we also
compared gene expression patterns using RNA from livers of
mice fed chow supplemented with either LE, where SREBP-2
nuclear levels are elevated (Figure 1), or cholesterol, where
nuclear levels of SREBP-2 are dramatically lower. A gene set
enrichment analysis (GSEA) for this comparison is plotted in
Figure 3A; the x axis presents a rank order of all genes according
to their differential expression (fold change and p value) in
LE- versus cholesterol-fed samples. The tick marks above the
plot indicate the presence of a ChIP-identified binding peak
near the gene sampled in the expression microarray, and the
relative peak density within the ranked gene list is also displayed
around the tick marks. The high peak density within the high
differentially expressed region of the GSEA revealed a very
high correlation between the two data sets (p = 2e14).
The motif-finding program MEME (Bailey, 2002) was next
applied to the sequences covered by the SREBP-2 peaks (Fig-
ure 3B). We found four motifs showing strong enrichment in
the SREBP-2 peak regions (with E values < 1.4 3 1031). Inter-
estingly, the highest-scoring motif corresponds to an SREBP
binding element that was defined by our previous studies using
sequence alignment, in vitro mutagenesis, and chemical probing
studies for recombinant SREBPs (Vallett et al., 1996). The
second-highest-scoring motif corresponds to an E box that is
prototypical of bHLH-LZ transcription factors. The generic E
box reads 50-CANNTG-30, and different bHLH proteins have
a preference for the bases in the middle (Murre et al., 1994). It
is interesting that the E box identified by our global analysis,
50-CACGTG-30, is identical to the preferred E box identified for
SREBPs by in vitro DNA site selection and mutagenesis (Kim
et al., 1995). The additional overrepresented motifs correspond
to consensus sites for NF-Y and Sp1, two transcription factors
known to function synergistically with SREBPs in transcriptional
activation (Osborne, 1995).
Because the SRE motif (motif 1 above) is an atypical binding
site for bHLH-LZ proteins, we used site-specific manual ChIP
to confirm SREBP-2 binding to several of the predicted SRE
motif peaks. We designed primers to amplify the regions over-
lapping 12 SRE-containing peaks, and there was significant
enrichment in all 12 with the SREBP-2-precipitated chromatin
(Table 1).
Next, we used the NIH Database for Annotation, Visualization,
and Integrated Discovery (DAVID) Gene Ontology (GO) software
(Dennis et al., 2003) to categorize the SREBP-2 ChIP-seq genes
by apparent functional annotation. In this analysis, broad biolog-
ical categories that were significantly represented were mostly
metabolic processes, and more specific categories included
lipid metabolic processes and cholesterol metabolism, as ex-
pected (Figure S4A). Several other categories were significantly
associated with the SREBP-2 ChIP-seq data set, including regu-
lation of apoptosis and autophagy (Figure S4B). SREBPs are
known to be substrates for the apoptotic caspase 3 in vitro,
and SREBP cleavage in cells can be induced by signals that
initiate apoptosis (Wang et al., 1996). However, there was no
prior suggestion that SREBPs might be associated with
autophagy.
Autophagy is a catabolic response cells utilize to adapt to
limiting nutrients in order to recapture and recycle cellularell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc. 369
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Figure 3. Analysis of SREBP-2 Peaks
(A) Gene Set Enrichment Analysis: KS plot. The gene list for the ChIP-seq peaks located within 20 kb of a known gene was compared for the peaks’ correlation to
expression of all mouse genes, rank-ordered for degree of differential expression in RNA isolated from livers of mice fed chow supplemented with LE versus chow
supplemented with cholesterol, as described in Experimental Procedures (Subramanian et al., 2005). All genes that were expressed based on the microarray
(2.53 104) were ranked by fold difference and p value (x axis), and the graph plots the running enrichment score on the ordinate. Here, many of the genes from
the ChIP-seq data set were located in the highly differentially expressed portion of the microarray data set, indicating that the genes identified by the ChIP-seq
analysis are differentially expressed in the liver of LE- versus cholesterol-fed mice (p value = 23 e14). The red vertical dotted line is drawn at the microarray gene
index corresponding to themaximum enrichment score (ES). Geneswith a corresponding adjacent peak have a tickmark above themain plot. To indicate relative
enrichment of the peak regions, peak region density is mirrored around the tick marks as indicated.
(B) Web logos for motifs present in SREBP-2 ChIP-Seq peaks. Four motifs were identified by runningMEME on the 1800 peak sequences. Motif 1 occurred in 892
of the peaks (E value = 1.43 10278), motif 2 occurred in 193 of the peaks (E value = 2.13 10070), motif 3 occurred in 231 of the peaks (E value = 7.83 10047),
and motif 4 occurred in 148 of the peaks (E value = 1.4 3 10031).
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SREBP-2 Regulates Autophagybuilding blocks, as well as to degrade damaged proteins
and whole organelles and to attack intracellular pathogens
(Mizushima and Klionsky, 2007; Mizushima and Levine, 2010;
Sumpter and Levine, 2010). SREBP-2 is key to the cells’
response to low levels of cellular sterols, a key class of cellular
nutrients. Cellular reserves of cholesterol are stored as choles-
terol esters within cytoplasmic LDs, along with TGs, and recent
observations suggest that liberation of stored lipids from within
these droplets may be mobilized by an autophagy-related
process (Singh et al., 2009). When autophagy was blocked by
knockdown of a critical autophagy protein, a significant fraction
of total cell TG and cholesterol accumulated within autophago-
somes (Singh et al., 2009). Additionally, sterol depletion has
been shown to induce autophagy directly (Cheng et al., 2006).
Thus, we reasoned that the activation of SREBP-2 during
autophagy might be an important part of the cellular nutrient
adaptation response to low sterols.
To analyze SREBP-2’s putative role in activation of genes
involved in autophagy during sterol depletion, we subjected
293 cells to a standard sterol depletion protocol known to induce
nuclear accumulation of SREBP-2 (Figure 4A). The autophagy
genes LC3B, ATG4B, and ATG4D were predicted as SREBP-2
targets from the ChIP-seq analysis (Figure S4B), and expression370 Cell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc.of all three was induced by sterol depletion similar to the induc-
tion of HMGCR analyzed as a control. The induction was depen-
dent on SREBP-2 because the inclusion of an siRNA targeting
SREBP-2 dramatically reduced the level of induction of all of
these genes, while having no effect on expression of the control
GAPDH gene.
We also cultured 293 cells overnight in the presence and
absence of serum and monitored the expression and maturation
of SREBP-2, as well as the conversion of LC3 into the lipidated
LC3-II form that occurs when autophagy is activated (Mizushima
et al., 2010). Serum starvation induced LC3-II formation, and this
was also significantly reduced by the siRNA targeting SREBP-2
(Figure 4B).
The LC3-II form accumulates within the autophagosomal
membrane prior to lysosomal fusion, and this can be evaluated
by the localization of LC3 into punctate immunostaining foci
(Mizushima et al., 2010). The LC3 staining in autophagosomes
was significantly increased after serum starvation, and this was
severely blunted by inclusion of the SREBP-2 siRNA (Figure 5).
LC3-II also accumulates within LD membranes targeted for lipo-
autophagy (Shibata et al., 2010; Singh et al., 2009), and our
hypothesis predicts that LC3-II association with LDs should
also be regulated by SREBP-2 levels. When we monitored the
Table 1. Peak Specific qPCR Validation for Binding Sites
Predicted by ChIP-Seq
Gene
Fold Change (SREBP-2/IgG)
Exp1 Exp2
Atg4b 3.35a 6.28a
Atg4d 1.7a 7.28a
Dhps 8.11a 3.91a
Mtf2 2.1b 3.29a
Mthfr 9.51a 8.69a
Mtmr2 2.46b 2.91a
Ncoa3 5.86b 3.8a
Pds5b 3.09b 2.25
Sirt1 2.93b 1.48
Snx13 9.1a 1.58a
Crk 1.67a 2.21b
Hiat1 9.23a 4.86a
Hmgcr 7.16a 20.16a
L32 0.89 1.38
Primer pairs were designed to amplify the predicted SREBP-2 binding
region from 12 genes predicted to harbor the SRE element, and two
separate sets of chromatin prepared from mice fed the LE diet and
enriched with the SREBP-2 antibody versus control IgG were analyzed
by qPCR. Hmgcr and L32 served as positive and negative controls,
respectively.
a p < 0.005.
b p < 0.05.
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Figure 4. SREBP-2 Regulates Autophagy-Related Gene Expression
(A and B) 293 cells were transfected with an siRNA (10 nM) for a negative
control siRNA (lanes 1 and 2) or siRNA targeting SREBP-2 (lanes 3 and 4).
Twenty-four hours after transfection, cells were cultured in 5% lipoprotein-
deficient media (LPDS) (lanes 2 and 4) or LPDS plus sterols (12 mg/ml
cholesterol and 1 mg/ml 25-hydroxycholesterol) (lanes 1 and 3) for 24 hr and
harvested for RNA or total protein (Sanchez et al., 1995). mRNA levels for
LC3B, ATG4B, ATG4D, HMGCR, and GAPDH were analyzed by RT-qPCR.
Relative expression is plotted (A). Whole-cell lysates were analyzed for
SREBP-2 or LC3 protein levels by immunoblotting. Data are representative of
three separate experiments. Data are mean ± SEM; n = 3 for three separate
experiments. HMGCR, HMG Co-A reductase; BP2i, SREBP-2 siRNA; NCi,
negative control siRNA (B).
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SREBP-2 Regulates Autophagycolocalization of LC3 with LDs, using immunofluorescence for
LC3 coupled with the fluorescent lipophilic dye BODIPY to stain
LDs, we observed an increase in LC3 association with LDs after
serum starvation and this association was also reduced by the
SREBP-2 siRNA (Figures 6A–6D and S5). The degree of colocal-
ization is unlikely to have been influenced by a potential artifact
resulting in red emission when the BODIPY green dye stained
LDs (Ohsaki et al., 2010), because incubation with BODIPY alone
did not result in any evidence of false colocalization (Figure S5D).
If SREBP-2 is essential for mobilization of LD contents through
lipoautophagy, then a knockdown of SREBP-2 during nutrient
depletion conditions should delay the disappearance of cellular
TG levels, similarly to the delay observed when the autophagy
pathway component ATG5 was targeted for knockdown (Singh
et al., 2009). Consistent with this idea, cellular TG mobilization
after nutrient depletion was delayed when SREBP-2 was
depleted (Figure 6E).DISCUSSION
We previously reported the genome-wide binding pattern for
SREBP-1 in hepatic chromatin and uncovered a preferred
binding motif that was not predicted from prior studies where
SREBP-1 association was evaluated one gene at a time (Seo
et al., 2009). Surprisingly, over 50%of the SREBP-1 binding sites
were localized to within 2 kb of the 50 end of known genes, which
is much higher than by chance (Chong et al., 2010) and higher
than for other transcription factors similarly analyzed to date
(Seo et al., 2009). The present study revealed an even strongerC50 proximal preference for SREBP-2, indicating this is a feature
shared by the two mammalian SREBPs.
In our analysis of SREBP-1, a software platform for peak
discovery was used that did not calculate an FDR along with
binding site identification. We focused on 467 peaks of
SREBP-1 binding that were identified simply by overrepresented
sequence reads and fold change from the background, as
described (Johnson et al., 2007). We independently calculated
that this corresponded to the very conservative FDR of 0.2%.
However, the GLITR program used here for SREBP-2 directly
calculates a p value and FDR for each peak, andwhen a relatively
conservative FDR of 1.5% was used, a total of 1800 genomic
binding sites for SREBP-2 were identified.
In order to perform a comparison of the binding profiles for
SREBP-1 versus SREBP-2, we first reanalyzed our SREBP-1
binding data using the GLITR program, with the same criteria
for peak identification as for SREBP-2. This resulted in 1597
genome-wide peaks for SREBP-1 and showed the same
promoter-proximal preference as before (Figure S6). When the
target genes for the two different SREBPs were analyzed for
overlap, 11.7% (187 out of 1597) of the SREBP-2 targets were
contained within the SREBP-1 data set. Although the pure
number of overlapping peaks between SREBP-1 and SREBP-2ell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc. 371
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Figure 5. SREBP-2 Is Required for Autophagosome Formation
(A–C) HeLa cells in 8-well chamber slides or 6-well plates were transfected
with SREBP-2 or negative control siRNA for 24 hr, and then cells were incu-
bated with media containing 5% LPDS in the absence (St) or presence (+St)
of sterols (12 mg/ml cholesterol and 1 mg/ml 25-hydroxycholesterol) for 24 hr.
Representative immunofluorescence images with LC3 antibody staining (A).
Quantitation of the percentage of cells with autophagosomes (B). Immuno-
blotting with SREBP-2 (IgG 1D2) antibody. Data are mean ± SEM; n = 3 for
three separate experiments. *p value < 0.05. Scale bar = 10 mm (C).
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Figure 6. SREBP-2 Deficiency Decreases Colocalization of Lipid
Droplets with Autophagosome and Triglyceride Mobilization
(A–D) HeLa cells in 8-well chamber slides were transfected with siRNA for
SREBP-2 or negative control siRNA for 24 hr; dishes were refed serum-
depleted media with oleic acid (0.1 mM) for 24 hr. Colocalization of LDs
(BODIPY 493/503, green) and autophagosome (LC3, red) (A–C). Quantitation
of colocalization of LDs with autophagosomes. 1, control; 2, BP2i (SREBP-2
siRNA); 3, NCi (negative control siRNA) (D). Data are mean ± SEM; n = 3 for 3
separate experiments. *p value < 0.001. Scale bar = 2 mm. In all experiments,
approximately 30 cells per sample were counted, and triplicate samples
were counted per experimental condition. Additional information is provided
in Experimental Procedures, and additional cell images are provided in
Figure S7.
(E) HeLa cells were transfected with SREBP-2 or negative control siRNA for
36 hr, and then cells were cultured with serum-depleted media for indicated
time. Triglyceride levels were measured from total cell lysates and normalized
with protein concentration. The p value was calculated using t test (n = 3, NCi
versus BP2i).
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SREBP-2 Regulates Autophagyis modest, their overlap is significant (p value < 106; if the peaks
were randomly distributed, <.05% of them would overlap).
The relatively modest overlap was lower than might have been
predicted, based on previous promoter studies in cultured cells
or from knockout and overexpression experiments in mice. In
these previous studies, both SREBPs were suggested to control
expression of many of the same genes; however, there were
some quantitative differences (Horton et al., 2002, 2003). At least
part of the reason for the low overlap may be that we used
different in vivo manipulations to selectively increase the nuclear
levels of each SREBP before chromatin isolation and ChIP-seq
analysis: refeeding following a fast for SREBP-1, and LE supple-
mentation for SREBP-2. Regardless, the results clearly demon-372 Cell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc.strate that, under conditions where each protein is specifically
increased in liver, they bindmostly to different sets of target sites
in the liver genome.
Results from both the GSEA and GO ranking are consistent
with SREBP-2 primarily activating genes involved in sterol
metabolism, which validates our approach and confirms the
quality of the data set. Additional GO categories relating to
apoptosis and autophagy were also significantly enriched.
SREBPs were shown to be associated with apoptosis soon after
Cell Metabolism
SREBP-2 Regulates Autophagytheir initial identification (Wang et al., 1996), but the current study
provides the first information for a potential link between
SREBPs and autophagy. In this regard, it is interesting that
studies showed that autophagy was induced upon cellular sterol
depletion (Cheng et al., 2006), which is ametabolic trigger for the
proteolytic maturation of SREBPs.
Direct knockdown studies (Figures 4 and 5) confirmed that
SREBP-2 both activates expression of key autophagy genes
and is important for the formation of autophagosomes during
cellular lipid depletion. Autophagy induction occurs very rapidly,
and a change in gene expression is not essential for its initial
induction (Mizushima et al., 2010). However, increased expres-
sion of autophagy-related genes through FoxO3 is associated
with skeletal muscle breakdown by autophagy in vivo (Mammu-
cari et al., 2007). Similarly, we propose that SREBP-2 selectively
activates autophagy genes during conditions where cell sterol is
limited and lipophagy is required to capture the lipid stored
within the intracellular LD. Consistent with this idea, we showed
that a decrease in SREBP-2 reduced association of LC3 with the
LD and delayed TG mobilization (Figure 6).
Sterol depletion is a selective form of nutrient depletion, and
many other situations that trigger autophagy are independent
of cell lipid metabolism. Additionally, as mentioned above, an
increase in gene expression is not essential to stimulate
autophagy (Mizushima et al., 2010). Thus, it is unlikely that
SREBP-2 is a general autophagy activator, but it may selectively
trigger the response when cells require new lipid. In fact, when
we measured LC3-II formation in cells following treatment
with either chloroquine or vinblastine, which block autophago-
some flux at the lysosomal degradation or the autophago-
some-lysosome fusion step, respectively, LC3-II formation
was not affected, even though SREBP-2 levels were reduced
(Figure S5E).
Most cells have the capacity to store at least small amounts of
cholesterol and fatty acids within cytoplasmic LDs as neutral
cholesterol esters and TGs, respectively, and a recent report
suggests that lipid contained within the droplets may be mobi-
lized through an autophagy-like process coinedmacrolipophagy
(Singh et al., 2009). Putting this observation together with our
ChIP-seq results, it was reasonable to hypothesize that genes
involved in the induction of autophagy might be activated in
response to conditions where cell sterols are limiting through
activation of SREBP-2, and our additional experiments support
this idea. Thus, the LD could be viewed as a third source of
cellular cholesterol, which, similarly to the de novo synthesis
and LDL receptor-mediated uptake pathways, is also regulated
by SREBP-2.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were performed in accordance with accepted stan-
dards of animal welfare and with permission of the University of California,
Irvine, IACUC (protocol 97-1545). Six-week-old male C57BL/6 mice were
obtained from Taconic (Hudson, New York) and maintained on a standard
rodent chow diet (2020X, Harlan Teklad Global, Placentia, CA) for 1 week
with a 12 hr light/12 hr dark cycle for acclimatization. Mice were separated
into three groups of six animals per group. One group was maintained on
a chow diet, and the other two groups were fed either normal chow supple-
mented with LE, a mixture of lovastatin (100 mg lovastatin [2.5 tablet equiva-Clents]/100 g chow, w/w; Mylan, Canonsburg, PA) and ezetimibe (21 mg ezeti-
mibe [2.1 tablet equivalents]/100 g chow, w/w; MERCK/Schering-Plough
Pharmaceuticals, Whitehouse Station, NJ), or powdered cholesterol (1%,w/w)
(Ch). All mice were sacrificed by CO2 asphyxiation at 8 a.m. (at the end of the
dark cycle).
Chromatin Preparation for ChIP Assay and ChIP-Seq
Chromatin preparation for ChIP assays and ChIP-seq using mouse livers was
performed as previously described (Bennett et al., 2008; Seo et al., 2009). For
gene-specific ChIP, qPCR for SREBP-2 binding to specific gene promoters
was analyzed in triplicate with a standard dilution curve of the input DNA per-
formed in parallel, and enrichment was measured by SYBR green incorpora-
tion using an iCycler (Bio-Rad, Hercules, CA). Analysis was performed by
the standard curve method, and values were normalized to a nontarget control
region from the ribosomal L32 gene. The qPCR oligonucleotide pairs for the
mouse promoters were as previously described (Seo et al., 2009) or are
included in Figure S7.
To prepare chromatin for the ChIP-seq, after isolating the ChIP-enriched
DNA, gene-specific enrichment for known SREBP-2 target promoters relative
to IgG control chromatin was verified. Twenty nanograms of ChIP-enriched
DNA or control DNA was sent to Ambry Genetics (Aliso Viejo, CA) for high-
throughput DNA sequencing. The samples were blunt ended, and adapters
were ligated to the ends, according to the library preparation protocol from
Illumina (San Diego, CA). Then DNA fragments 200 ± 25 bp in length were
selected for the construction of the ChIP-seq DNA library. After size selection,
all the resulting ChIPed DNA fragments were amplified and sequenced simul-
taneously using Solexa/Illumina Genome Analyzer II.
For qPCR validation of motif 1 target sites, 12 randomly selected peakswere
chosen for validation by gene-specific ChIP. Chromatin from the LE samples
was analyzed with primers designed to flank the peaks and to produce
a PCR product of 200 bases. The fold change is the fold increase for the
signal from SREBP-2-antibody-enriched chromatin, relative to a control reac-
tion where a control IgG fraction was used in place of the SREBP-2 antibody.
Preprocessing ChIP-Seq Data
The ChIP-seq data set was analyzed to determine peaks that contain binding
sites of SREBP-2 to its target genes. Short reads of 39 bp were produced from
Solexa/Illumina Genome Analyzer II and mapped to a reference genome by
Ambry Genetics using ELAND, allowing one mismatch. Short sequence reads
that mapped to simple and complex repeats or that were not unique by chance
were removed from the analysis. We converted these files to BED files using
the ChIP-seq mini 2.0.1 suite developed by the Wold lab at California Institute
of Technology (Johnson et al., 2007). The BED files were used as input to
downstream processing, as well as visualization in the UCSC Genome
Browser (http://genome.ucsc.edu/index.html).
Finding Peaks and Distance from Peak to TSSs
To determine where the SREBP-2 bound to the genome, we looked for areas
where there were significantly more enriched reads mapped in the ChIP
sample than in the IgG. This was accomplished using GLITR (Tuteja et al.,
2009). For each peak, the distance from the peak to the nearest TSS was
determined and plotted. The TSSs were taken from a RefSeq file obtained
fromNCBI. The backgroundwas determined by placing peaks at random loca-
tions on the genome and by determining distances to TSS.
Motif Analysis
DNA sequences were retrieved using Galaxy (http://main.g2.bx.psu.edu) and
used for motif search using MEME (Bailey, 2002). MEME represents motifs as
position-dependent, letter-probabilitymatrices (PWMs) andwas used to score
cut-off represented as a Z-score. Sampling the genome hundreds of thou-
sands of times, we determined a background score distribution and used
a Z-score threshold of 4.27 when searching for instances of the MEME motifs.
Annotation of Genes and GO Analysis
All SREBP-2 binding sites were assigned to nearest genes based on the Mus
musculus NCBI genome assembly (mm9; July 2007). GO analysis of SREBP-2
target genes was conducted by using the DAVID NIH software (http://david.
abcc.ncifcrf.gov/) (Dennis et al., 2003). This analysis was used to classify theell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc. 373
Cell Metabolism
SREBP-2 Regulates Autophagynearest gene list into functionally related gene groups by using the ‘‘PANTHER
Biological Process’’ term.
Kolmogorov-Smirnov Analysis
The obtained ChIP-seq data was compared with expression microarray data
by using a Kolmogorov-Smirnov (KS) plot, a modified method of GSEA
(Subramanian et al., 2005). The KS plot tests the null hypothesis that the ranks
of the genes identified by ChIP-seq are uniformly distributed throughout the
SREBP-2 expression microarray. KS plot was obtained by calculating the
running sum statistics for our ChIP-seq gene set to observe enrichment in
the ranked gene list from the expression microarray data.
Cell Culture and RNA Interference
293 and HeLa cells are were maintained in Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 10% heat-inactivated fetal calf serum
(FCS) and antibiotics in an atmosphere of 5% CO2 at 37
C. The siRNA target-
ing human SREBP-2 (sc-36559) and siRNA control (sc-37007) were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). The cells were transfected
for 24 hr with 10 nM of each siRNA by using Lipofectamine RNAiMAX reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions, and
dishes and chamber slides were washed and refed with media with or without
serum for 24 hr. To block autophagic flux, HeLa cells were incubated with
complete media containing 50 mM chloroquine (Sigma-Aldrich, St. Louis,
MO) for 6 hr.
RNA Isolation, RT-qPCR, and Gene Expression Profiling
Total RNA was isolated from mouse liver and 293 cells with TRIzol (Invitrogen)
and QIAGEN RNAeasy isolation kits (QIAGEN, Valencia, CA) and used for RT-
qPCR with an iQ5 Real-Time PCR Detection System (Bio-Rad). Primer
sequences used in this study were shown in Figure S7. mRNA levels were
normalized for expression of mouse ribosomal protein L32 and human glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) mRNA as control and calcu-
lated by the comparative threshold cycle method. Gene expression profiling
was carried out using the Mouse Gene 1.0 OST (Affymetrix, Santa Clara, CA)
by hybridizing RNA from LE and Ch livers in triplicate at the Sanford-Burnham
Genomics Core facility (Lake Nona, FL). Differential expression was then
assessed using the Partek Genomics Suite (Partek Inc., St. Louis, MO) and
cyberT (Long et al., 2001).
Immunoblotting
Polyclonal rabbit anti-SREBP-2 antibody against mouse SREBP-2 was gener-
ated as previously described (Jeon et al., 2008). Hepatic nuclear proteins and
whole-cell lysates were subjected to SDS-PAGE (10% or 12%), followed by
transfer to polyvinylidene difluoride membranes. The membranes are incu-
bated with anti-SREBP-2 antiserum for mouse, anti-SREBP-2 (1D2) for
human, anti-LC3B (Cell Signaling, Danvers, MA), anti-YY1 (Santa Cruz
Biotechnology), and anti-b-actin (Sigma-Aldrich) as primary antibodies. After
incubation with horseradish peroxidase-conjugated secondary antibodies,
blots were developed using the SuperSignal West Femto Maximum Sensitivity
Substrate from Thermo Scientific, Inc. (Waltham MA).
Immunofluorescence and Immunohistochemistry
Sections of paraffin-embedded livers were dewaxed in xylene and rehydrated,
and antigen retrieval was performed with 10 mM citrate buffer. Sections were
blocked for 30 min in 1% BSA, 0.02% Triton X-100, and 10% normal goat
serum (NGS). Serial sections were incubated with SREBP-2 antibody (1:500)
and then incubated with Cy5-conjugated goat anti-rabbit secondary antibody
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). The sections
are mounted by Vectashield with DAPI (Vector Laboratories, Burlingame, CA).
Images from serial sections were acquired by an inverted microscope,
Axioskop, using the AxioVision camera and software (Zeiss, Thornwood, NY)
(Jeon et al., 2008). For immunocytochemistry, HeLa cells were fixed with 4%
paraformaldehyde, permeabilized with 0.25% Triton X-100, blocked with
10% NGS, and incubated with anti-LC3B primary antibody followed by Alexa
Fluor 488-conjugated goat anti-rabbit secondary antibody before mounting.
LDs were stained by incubating cells with BODIPY 493/503 (Invitrogen) for
30 min and were fixed and processed for immunofluorescence as described
above. Images from cells were acquired with a Laser Scanning Confocal374 Cell Metabolism 13, 367–375, April 6, 2011 ª2011 Elsevier Inc.microscope (A1R VAAS with 3 60/numerical aperture 1.49 oil-immersion
lens, Nikon, Melville, NY) along with NIS-Elements AR software (Nikon). In all
experiments, approximately 30 cells per sample were counted, and triplicate
samples were counted per experimental condition. Quantification for auto-
phagy was performed in deconvoluted and threshold-limited images using
the ‘‘Analyze Particle’’ function in ImageJ software (NIH). For quantification
of colocalizations, the ImageJ JACoP plug-in (Bolte and Cordelie`res, 2006)
was used to calculate the percentage of colocalization from Manders’s over-
lapping coefficients (fraction of red overlapping green) (Manders et al., 1992).
Statistics
The data are presented asmean ± SEM. Differences between themeans of the
individual groups were assessed by one-way ANOVA with Dunnett’s multiple
comparison test; differences were considered significant at p value < 0.05. The
statistical software package Prism 5.0 (GraphPad Software, La Jolla, CA) was
used for these analyses.
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